FDA Approves Groundbreaking New Painkiller After Decades of Research
FDA Approves Suzetrigine: A Groundbreaking Non-Opioid Pain Medication In a landmark decision, the U.S. Food and drug Management (FDA) has approved suzetrigine,branded as Journavx,a novel non-opioid medication for treating moderate-to-severe acute pain in adults. This approval marks the first new class of pain medicine in over two decades and offers a promising alternative to opioids, … Read more